Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer. [electronic resource]
Producer: 20130730Description: 710-8 p. digitalISSN:- 1569-8041
- Adenocarcinoma -- drug therapy
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Capecitabine
- Cardiovascular Diseases -- chemically induced
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Double-Blind Method
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Recombinant Fusion Proteins -- administration & dosage
- Stomach Neoplasms -- drug therapy
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.